Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Recruitment |
Recruitment rate will be assessed as the number of patients recruited out of the number of eligiable patients |
Assessed at 3 months |
|
Primary |
Retention |
Retention rate will be assessed as the number of patients who wtihdrew from the study out of the total number of patients. |
Assessed at 9 months |
|
Primary |
Adherence |
Adherence to intervention protocol of the study assessed as the number of sessions attended out of the total number of sessions available |
Assessed at 9 months |
|
Secondary |
Physical activity measured by the Physical activity and sedentary time questionnaire (FAST) |
Physical activity measured by the Physical activity and sedentary time questionnaire (FAST) |
Assessed at baseline and 9 months |
|
Secondary |
Pain intensity measured by the Visual analog scale for pain (VAS) |
Pain measured by the Visual analog scale for pain. Score from 0-100. Higher score is more pain. |
Assessed at baseline and 9 months |
|
Secondary |
Functional status measured by the Multi-Dimensional Health Assessment Questionnaire (MD-HAQ) |
Functional status measured by the Multi-Dimensional Health Assessment Questionnaire. Score from 0-3. Higher score is more disability. |
Assessed at baseline and 9 months |
|
Secondary |
Fatigue measured by the Bristol Reumatoid Arthritis Fatigue Questionnaire (BRAF) |
Fatigue measured by the Bristol Reumatoid Arthritis Fatigue Questionnaire (BRAF). It consists of 20 questions with four responses in four categories: physical fatigue, living with fatigue, cognitive fatigue, and emotional fatigue. Higher score is more fatigue. |
Assessed at baseline and 9 months |
|
Secondary |
Fatigue measured by the visual analog scale for fatigue (VAS-fatigue) |
Fatigue measured by the visual analog scale for fatigue (VAS-fatigue). Score from 0-100. Higher score is more fatigue. |
Assessed at baseline and 9 months |
|
Secondary |
Health Literacy was measured by the Health Literacy Questionnaire (HLQ) |
Health Literacy was measured by the Health Literacy Questionnaire. Independent scales measuring health literacy on a continuous scale. Scores range between 1 to 4 (for first 5 scales) and 1 to 5 (for scales 6 to 9). |
Assessed at baseline and 9 months |
|
Secondary |
Health related quality of life measured by the EuroQol-5 Dimension (EQ5D) |
Quality of life measured by the EuroQol-5 Dimension. measures the patient's self-rated health status. Ranging from -0.624 to 1, higher is better. |
Assessed at baseline and 9 months |
|
Secondary |
Illness perception measured by the Brief Illness Perception Questionnaire (B-IPQ) |
Illness perception measured by the Brief Illness Perception Questionnaire. Score from 1-10. Higher is worse. |
Assessed at baseline and 9 months |
|
Secondary |
Self-efficacy measured by the Arthritis specific self-efficacy measurement tool (ASES) |
Self-efficacy measured by the Arthritis specific self-efficacy measurement tool. Score from 1-10. Higher score is better |
Assessed at baseline and 9 months |
|
Secondary |
Anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS) |
Anxiety and depression measured by the Hospital Anxiety and Depression Scale. ). HADS is a 14-item questionnaire that assesses levels of anxiety and depression symptoms in medically ill patients in two 7-item sub-scales, one for anxiety (HADS-A) and one for depression (HADS-D). Scores of 8 to 10 suggest the presence of a mood disorder. Scores of 11 or higher indicate the probable presence of a mood disorder. Symptoms of anxiety and depression were defined by scores of 8 or higher. |
Assessed at baseline and 9 months |
|
Secondary |
Disease activity RA measured the Disease Activity Score in 28 joints (DAS28) |
Disease activity in rheumatoid arthritis, measured the Disease Activity Score in 28 joints with erythrocyte sedimentation rate. Composite measures, in which multiple aspects of the disease are combined in a total score of the level of disease activity. Higher is worse. |
Assessed at baseline and 9 months |
|
Secondary |
Disease activity SpA measured by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) |
Disease activity in patients with spondyloarthritis, was measured by the Bath Ankylosing Spondylitis Disease Activity Index. The sum score ranges from 0 to 100 with higher values indicating more active disease |
Assessed at baseline and 9 months |
|
Secondary |
Disease activity PsA measured by the the Disease Activity index for PSoriatic Arthritis (DAPSA). |
Disease activity in patients wiht psoriatic arthritis, was measured by the Disease Activity index for PSoriatic Arthritis. Composite measures, in which multiple aspects of the disease are combined in a total score of the level of disease activity. Higher is worse. |
Assessed at baseline and 9 months |
|